Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17540273 | 0.82 | ALDH1A1 (0.44) | ALDH1A1KMT2AMAPTL3MBTL1HTR2C | |
| SCHEMBL17400444 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KMT2AMAPTL3MBTL1 | |
| SCHEMBL17540288 | 0.77 | ALDH1A1 (0.40) | PRSS1PRSS2PRSS3ALDH1A1CYP3A4 | |
| SCHEMBL17400432 | 0.74 | HTR2C (0.47) | TDP1CYP1A2HTR2C | |
| SCHEMBL17540278 | 0.72 | GLS (0.35) | CYP1A2HTR2C | |
| SCHEMBL9069615 | 0.69 | HTR2C (0.44) | HTR2C | |
| SCHEMBL10454506 | 0.69 | ALDH1A1 (0.61) | PRSS1PRSS2PRSS3ALDH1A1CYP3A4 | |
| SCHEMBL30532537 | 0.69 | PRSS1 (0.97) | PRSS1PRSS2PRSS3ALDH1A1CYP3A4 | |
| SCHEMBL30532536 | 0.69 | PRSS1 (0.97) | PRSS1PRSS2PRSS3ALDH1A1CYP3A4 | |
| SCHEMBL28396810 | 0.69 | PRSS1 (0.97) | PRSS1PRSS2PRSS3ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9923143-B2 | Fullerene derivative, organic solar cell using same, and manufacturing method thereof | LG CHEM, LTD. (KR) | 2018-03-20 | — | — | US | disclosed |
| US-20160056383-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF | LG CHEM, LTD. (KR) | 2016-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160056383-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF | FTO, SUN2, CRY2 | PRSS1 3905/4885PRSS2 3391/4885PRSS3 4330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.